Capmatinib and gefitinib combination therapy: will EGFR-mutated MET-dysregulated NSCLC “capitulate”?

Brian Ko, Balazs Halmos

Research output: Contribution to journalEditorialpeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)S321-S325
JournalTranslational Lung Cancer Research
Volume7
DOIs
StatePublished - Dec 2018
Externally publishedYes

ASJC Scopus subject areas

  • Oncology

Cite this